Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
Read Now: TheBodyPRO.com Covers AIDS 2014
  
  • Email Email
  • Comments Comments
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

"Drugs That Fight HIV" Brochure Recently Updated

July 26, 2013

NIAID recently updated the "Drugs That Fight HIV" brochure, which features images of FDA-approved antiretroviral medications, grouped by drug class and clearly identified by both generic and brand names. The brochure can be used by health care professionals when discussing HIV treatment with patients.

The brochure includes the addition of three drugs:

  • Rilpivirine (brand name: Edurant), a non-nucleoside reverse transcriptase inhibitor (NNRTI), approved May 2011.
  • Emtricitabine/rilpivirine/tenofovir (brand name: Complera), a combination drug, approved August 2011.
  • Elvitegravir/cobicistat/emtricitabine/tenofovir (brand name: Stribild), a combination drug, approved August 2012.

Other additions include brief descriptions of each drug class and new drug formulations with accompanying images.



  
  • Email Email
  • Comments Comments
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

This article was provided by AIDSinfo. Visit the AIDSinfo website to find out more about their activities and publications.
 
See Also
HIV Medications: When to Start and What to Take -- A Guide From TheBody.com
More on HIV Medications

No comments have been made.
 

Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)

Your Name:


Your Location:

(ex: San Francisco, CA)

Your Comment:

Characters remaining:

Tools
 

Advertisement